MedPath
HSA Approval

SALONPAS DICLOFENAC PATCH 1%

SIN16546P

SALONPAS DICLOFENAC PATCH 1%

SALONPAS DICLOFENAC PATCH 1%

July 7, 2022

HISAMITSU PHARMACEUTICAL CO., INC. SINGAPORE BRANCH

HISAMITSU PHARMACEUTICAL CO., INC. SINGAPORE BRANCH

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantHISAMITSU PHARMACEUTICAL CO., INC. SINGAPORE BRANCH
Licence HolderHISAMITSU PHARMACEUTICAL CO., INC. SINGAPORE BRANCH

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

PATCH, EXTENDED RELEASE

**Directions:** **Adults and children 15 years of age and over:** Clean and dry affected area. Remove patch from backing film and apply to skin. Apply 1 patch to the affected area and leave in place for up to 24 hours. Do not use more than 2 patches per day. **Children under 15 years of age:** Do not use.

TOPICAL

Medical Information

**Indications:** For relief of aches, pains and inflammation associated with: - muscle pain - stiff shoulder - backache - bruises - sprains - strains - joint pain - tendons inflammation - elbow pain

**Contraindications:** **Do not use** - on wounds or damaged skin. - on eyes, mucous membranes or rashes. - on suppurating area because of the risk of masking underlying skin infections. - if you are allergic to any ingredients of this product. - if you are pregnant. - if you are with a history of asthma. - on children under 15 years of age.

M02AA15

diclofenac

Manufacturer Information

HISAMITSU PHARMACEUTICAL CO., INC. SINGAPORE BRANCH

Hisamitsu Pharmaceutical Co., Inc. Utsunomiya Factory

Active Ingredients

Diclofenac Sodium

1% w/w

Diclofenac

Documents

Patient Information Leaflets

Inner Labels_3patches per pouch PIL.pdf

Approved: July 7, 2022

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SALONPAS DICLOFENAC PATCH 1% - HSA Approval | MedPath